Adju-Phos®

Adju-Phos®

Pharma

Information

Adju-Phos is a range of aluminium phosphate gel products which have been specifically developed for use as an adjuvant in vaccines. The gel is a suspension of hydrated amorphous aluminium hydroxyphosphate nano/micron size crystals in loose aggregates. Adju-Phos products have a net negative charge at neutral pH and effectively adsorb positively charged antigens. The primary purpose of the adjuvant in vaccines is to boost the antibody-mediated (Th2) immune response. Adju-Phos products can be combined with other adjuvant types (such as monophosphoryl lipids) to achieve a balanced Th1/Th2 immune response.
CrodaCroda International Plc, a specialty chemical company providing high purity and high quality excipients for drug and vaccine development, has recently strengthened their offering with significant investment in the area of vaccine adjuvants. Providing customers with over 80 years of adjuvant expertise, our Vaccine Adjuvants Division (formerly Benntag Biosector) has unprecedented industry experience as a vaccine adjuvant specialist. In addition to supplying industry renowned aluminium- and saponin-based adjuvants, including the well-known brands Alhydrogel®, Adju-Phos® and Quil-A®, Croda is committed to developing the next generation of adjuvant technology, with a robust innovation pipeline focusing on enhanced protein binding and immune-stimulating nanotechnology. Additionally, this year Croda has acquired Avanti Polar Lipids, extending its portfolio and expertise in the area of vaccine adjuvants and immunology. Engage with our team today to learn more about how we can help you with your vaccine development needs!

Log in